MPZL3
Myelin protein zero-like protein 3
Also known as: MPZL3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UWV2
- Gene
- MPZL3
- Ensembl
- ENSG00000160588
- Chromosome
- 11
- Canonical length
- 235 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Predicted to be involved in cell adhesion. Predicted to act upstream of or within extracellular matrix organization and hair cycle. Predicted to be located in membrane. Predicted to be active in plasma membrane. Implicated in lung cancer. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>Q6UWV2|MPZL3
1 MQQRGAAGSR GCALFPLLGV LFFQGVYIVF SLEIRADAHV RGYVGEKIKL KCTFKSTSDV
61 TDKLTIDWTY RPPSSSHTVS IFHYQSFQYP TTAGTFRDRI SWVGNVYKGD ASISISNPTI
121 KDNGTFSCAV KNPPDVHHNI PMTELTVTER GFGTMLSSVA LLSILVFVPS AVVVALLLVR
181 MGRKAAGLKK RSRSGYKKSS IEVSDDTDQE EEEACMARLC VRCAECLDSD YEETYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MPZL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 32 nTPM
- skin: 29 nTPM
- vagina: 17 nTPM
- tonsil: 12 nTPM
- cervix: 11 nTPM
- salivary gland: 11 nTPM
Single-cell type
- esophageal apical cells: 694 nCPM
- t-cells: 231 nCPM
- enterocytes: 215 nCPM
- ocular epithelial cells: 206 nCPM
- innate lymphoid cells: 202 nCPM
- neutrophils: 146 nCPM
Immune cell
- eosinophil: 99 nTPM
- neutrophil: 88 nTPM
- basophil: 44 nTPM
- MAIT T-cell: 29 nTPM
- memory CD4 T-cell: 11 nTPM
- memory CD8 T-cell: 9.6 nTPM
Brain region
- cerebellum: 6.2 nTPM
- choroid plexus: 4.1 nTPM
- pons: 2.5 nTPM
- basal ganglia: 2.4 nTPM
- hypothalamus: 2.2 nTPM
- thalamus: 2.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.31
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MPZL3 as an antibody target. Whether an autoantibody or antibody against MPZL3 could matter depends on whether native MPZL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MPZL3 is annotated at the cell surface, where native MPZL3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MPZL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...